Ads
related to: alcon pharmaceutical jobsjoblist.com has been visited by 100K+ users in the past month
- Full Time Jobs
Find Full Time Jobs Near You.
Hiring Immediately - Apply Now!
- New Pharmaceutical Jobs
1000s of Pharmaceutical Jobs.
See Which Companies Are Hiring!
- Find A Job Near You
The Top Jobs, All In One Place.
Start Your Search Here - Apply Now!
- High Paying Jobs
Find High Paying Jobs Near You.
Search The Top Paying Jobs Now!
- Full Time Jobs
us.jobrapido.com has been visited by 1M+ users in the past month
Large Employment Site (>10 Million Unique Visitors Per Month) - TAtech
Search results
Results From The WOW.Com Content Network
Alcon Inc. Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...
Alcon relocated its headquarters to Geneva in 2018, citing an opportunity to “increase Alcon’s global scale and reach to better serve customers.” The company employs a total of 25,000 people.
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.